Knowledge • News • Insights

In Partnership With

Your marketing shouldn't be a hot mess. Let's fix it together.

MICHBIO: Stay informed. Stay Connected. BioLink 2.23.26.

Michigan Business Network: MichBIO

Akadeum Life Sciences CEO Brandon McNaughton Named Entrepreneur of the Year

CEO of Akadeum Life Sciences, Brandon McNaughton, was recently recognized as Entrepreneur of the Year by the New Enterprise Forum. This honor reflects the work being done at Akadeum and the incredible ecosystem supporting life science innovation in the region. >> LEARN MORE

Entirety BioMedical Closes $1.2M Seed Round

Entirety Biomedical has secured $1.2 million in seed financing to advance its innovative biomedical platform and accelerate next-stage development. The round positions the company for continued growth and expanded impact in the sector. >> LEARN MORE

U-M BME’s Prof. Zhen Xu Named to TIME 100 Health List

The University of Michigan’s Department of Biomedical Engineering celebrates Prof. Zhen Xu’s recognition as one of TIME’s 100 Most Influential Leaders in Health for 2026. The honor highlights her groundbreaking contributions to medical innovation and patient impact. >> LEARN MORE

Codifying MFN Drug Pricing Could Undermine Biopharma Innovation

As Congress weighs codifying Most Favored Nation (MFN) drug pricing into law, leaders from PhRMA and the Biotechnology Innovation Organization (BIO) are warning that tying U.S. drug prices to those in other countries could undermine biopharma investment and innovation. Industry advocates argue that importing international reference pricing could reduce incentives for breakthrough therapies, impact deal economics and R&D investment, and weaken U.S. leadership in life sciences. >> READ MORE

FDA to Adopt Single-trial Default Policy – Implications for Biopharma and Vaccine Innovation

The U.S. Food and Drug Administration (FDA) has announced a major policy shift that would treat a single well-designed pivotal trial—supported by confirmatory evidence—as the default standard for demonstrating safety and efficacy. The move could shorten development timelines, reduce costs, and accelerate patient access, though questions remain about how the policy will apply to vaccines and complex biologics. >> READ MORE

MichBio Supports Renewal of SmartZone TIF Authority

MichBio is backing HB 5031 to renew Michigan’s SmartZone Tax Increment Financing (TIF) authority, a cornerstone of the state’s innovation and commercialization ecosystem. For more than two decades, SmartZones have helped launch high-growth companies, attract investment, and strengthen Michigan’s life sciences and technology sectors—making renewal critical to maintaining the state’s competitive edge. >> READ MORE

MichBio Supports SB 704 to Strengthen Cannabis Testing Standards

MichBio has voiced support for SB 704, legislation that would establish a State Reference Laboratory to improve oversight, consistency, and scientific integrity in Michigan’s cannabis testing system. The proposal aims to address potency discrepancies and lab variability, protect consumers, and ensure fair competition through uniform, validated testing standards. >> READ MORE

NEW! MichBio IP & Legal Webinar Series

A two-part virtual series on inventorship and IP management.

Congratulations, You Just Added an Inventor Thurs., April 9, 2026 – 11:00 AM
Inventorship turns on ‘conception, not effort—someone who wrote the code or built the hardware may not be an inventor, while advisors, customers, or other contributors sometimes are. These errors are often silent, easy to miss, and frequently discovered only during diligence or enforcement, when they’re hardest to fix (if they are fixable at all). Joint inventorship can be more complicated, requiring a person to share in the conception of a claimed invention to be so titled. This session clarifies how inventorship actually works in modern teams in the U.S. and internationally, offers practical decision tools for identifying true inventors, and shows how to document conception boundaries before “helpful input” becomes a legal problem.
Presenters:
  • Ashley Sloat, Ph.D, President, Director of Patent Strategy, Aurora Consulting
  • Tom Moga, Member, Dykema
REGISTER
Inventors as Employees: Managing the IP Created by Your Team Thurs., April 16 – 11:00 AM
The question of who owns employee-created intellectual property is not always a straightforward answer. However, there are some simple steps that employers can take to not only assure that their rights are protected but to also maintain transparent policies that are understood and embraced company-wide. Join us for a discussion on the types of policies and agreements that can take the uncertainty out of IP ownership for businesses. We will address how these issues are best managed in the United States as well nuances and considerations for businesses and employees abroad.
Presenters:
  • Melvin Muskovitz, Senior Counsel, Dykema
  • Kristen Pursley, IP Attorney/Registered Patent Attorney, The Dobrusin Law Firm
  • Tina Suntres, MSc, MBA, Assistant Director, Software, Content Licensing and Research Partnerships, University of Michigan
REGISTER  

What's Hot

Get the latest news from MBN right in your inbox

Sign up for our newsletter and never miss a beat.